Inventor · disambiguated record
Jeffery Fairman
Also filed as: FAIRMAN JEFFERY · FAIRMAN JEFFERY C
9 granted patents·12 pending applications·17 citations·filing 2002–2025
82Inventor score
Top patents by PatentIndex Score
21 records- 0185US11951165B2Conjugated vaccine carrier proteinsVAXCYTE INC·Filed 2019·Granted Apr 9, 2024·3 cites·4 claims
- 0285US11701414B2Periodontitis vaccine and related compositions and methods of useVAXCYTE INC·Filed 2021·Granted Jul 18, 2023·1 cites·29 claims
- 0384US12252454B2Carrier-protein polysaccharide conjugation methodsVAXCYTE INC·Filed 2023·Granted Mar 18, 2025·1 cites·29 claims
- 0481US11998599B2Polypeptide-antigen conjugates with non-natural amino acidsVAXCYTE INC·Filed 2017·Granted Jun 4, 2024·2 cites·17 claims
- 0579US12121575B2Periodontitis vaccine and related compositions and methods of useVAXCYTE INC·Filed 2023·Granted Oct 22, 2024·0 cites·21 claims
- 0678US10835590B2Periodontitis vaccine and related compositions and methods of useVAXCYTE INC·Filed 2018·Granted Nov 17, 2020·2 cites·43 claims
- 0774US8945590B2Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)FAIRMAN JEFFERY·Filed 2009·Granted Feb 3, 2015·8 cites·15 claims
- 0870US2024342274A1Polypeptide-antigen conjugates with non-natural amino acidsVAXCYTE INC·Filed 2024·Application pending·0 cites
- 0969US2024358823A1Conjugated vaccine carrier proteinsVAXCYTE INC·Filed 2024·Application pending·0 cites
- 1066US2009169612A1Systemic Immune Activation Method Using Nucleic Acid-Lipid ComplexesJUVARIS BIO THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1160US12280097B2Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of useVAXCYTE INC·Filed 2021·Granted Apr 22, 2025·0 cites·24 claims
- 1257US2004247662A1Systemic immune activation method using nucleic acid-lipid complexesFiled 2004·Application pending·0 cites
- 1356US2023293658A1Group a strep immunogenic compositions with polysaccharide-protein conjugatesVAXCYTE INC·Filed 2022·Application pending·0 cites
- 1455US2010086584A1VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDESJUVARIS BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1553US2025214912A1Carrier-protein polysaccharide conjugation methodsVAXCYTE INC·Filed 2025·Application pending·0 cites
- 1651US2025269004A1Enterococcus faecalis vaccine and uses thereofVAXCYTE INC·Filed 2023·Application pending·0 cites
- 1749US2003162255A1Type-C lectins and methods of useFiled 2003·Application pending·0 cites
- 1849US2003092028A1Methods and Reagents For Diagnosis and Treatment of Insulin Resistance and Related ConditionFiled 2002·Application pending·0 cites
- 1943US9089537B2Subunit vaccines for herpes viruses and methods of useFAIRMAN JEFFERY·Filed 2011·Granted Jul 28, 2015·0 cites·17 claims
- 2042US2005181035A1Systemic immune activation method using non CpG nucleic acidsFiled 2004·Application pending·0 cites
- 2141US2005013812A1Vaccines using pattern recognition receptor-ligand:lipid complexesFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →